Data availability
Methods and supporting data are available in Supplementary Methods.
References
Williams, M. J., Werner, B., Barnes, C. P., Graham, T. A. & Sottoriva, A. Nat. Genet. 48, 238–244 (2016).
Sims, D., Sudbery, I., Ilott, N. E., Heger, A. & Ponting, C. P. Nat. Rev. Genet. 15, 121–132 (2014).
Weinstein, J. N. et al. Nat. Genet. 45, 1113–1120 (2013).
Bansal, V. Bioinformatics 26, i318–i324 (2010).
Andor, N. et al. Nat. Med. 22, 105–113 (2016).
Acknowledgements
S.D. acknowledges support from NIH grant P30CA072720.
Author information
Authors and Affiliations
Contributions
A.B. contributed to data analysis. S.D. conceived the project, contributed to data analysis, interpreted the results, and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Supplementary information
Supplementary Text and Figures
Supplementary Methods
Rights and permissions
About this article
Cite this article
Balaparya, A., De, S. Revisiting signatures of neutral tumor evolution in the light of complexity of cancer genomic data. Nat Genet 50, 1626–1628 (2018). https://doi.org/10.1038/s41588-018-0219-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41588-018-0219-4
- Springer Nature America, Inc.
This article is cited by
-
Neutral Theory is a tool that should be wielded with care
Nature Human Behaviour (2021)
-
Neutral syndrome
Nature Human Behaviour (2020)
-
An enhanced genetic model of relapsed IGH-translocated multiple myeloma evolutionary dynamics
Blood Cancer Journal (2020)
-
Somatic substitution signature as an innovative tool in lung cancer diagnosis
Scientific Reports (2019)
-
Reply to ‘Revisiting signatures of neutral tumor evolution in the light of complexity of cancer genomic data’
Nature Genetics (2018)